©2019 by Galea Therapeutics Inc.     -     info@galeatherapeutics.com      -     Privacy Policy

Scientific Team

Leading investigator in the Cannabinoid System, Feeding and Addiction Behavioral Disorders.

  • Principal Investigator and Head of Neuropsychopharmacology research programs at IBIMA Research centre (Malaga Hospital System). "Nicolas Monardes" Senior Chair in Research.

  • Head of Neuropsychopharmacology research group, Complutense University, School of Psychology (Madrid). 

  • National Coordinator Spanish Research Network on Drug Addiction, Instituto de Salud Carlos III, Health Department, Government of Spain.

  • 21 patents granted, 297 published scientific articles, 71 research grants awarded, 1 International and 3 National research awards, and 153 papers presented at international conferences.

  • Post-Doctoral Fellow, Scripps Research Institute (USA); 

  • Post-Doctoral Fellow, University of California (USA); 

  • Ph.D. Biochemistry and Molecular Biology, U. Complutense of Madrid; 

  • M.D. Medicine-Surgery UCM.

Leading Medical Scientist focused on medical complications of substance abuse. Internal Medicine specialist with emphasis in viral infections and alcoholic liver disease.

  • Director, Addiction treatment Unit, University Hospital Germans Trias i Pujol, Badalona.

  • PI in Clinical Research, IGTP Research Center at University Hospital Germans Trias i Pujol, Badalona.

  • Professor of Medicine, Autonomous University of Barcelona School of Medicine.

  • Visiting Professor, Johns Hopkins University, Baltimore.

  • M.Sc. Public Health, Johns Hopkins University School of Medicine, Baltimore.

  • MD, U. of Barcelona

  • Fulbright Scholar 2016-17 Johns Hopkins University.

Expert in Neuropsychopharmacology of Ingestive Behaviors and Drug Addiction.

  • Co-discoverer of key physiological and pharmacological modulators of addictive behaviour.

  • Co-Group Leader Neuropharmacology of Ingestive Behavior and Addiction research team at Complutense University of Madrid (UCM).

  • Director, M.Sc. Program in Psychopharmacology and Drugs of Abuse UCM.

  • Professor, Psychobiology and Behavioral Sciences UCM.

  • 118 scientific publications and meeting presentations, and 29 Research grants.

  • 2015 Award, International Drugs of Abuse Research Society.

  • Fulbright Postdoctoral Fellow, the Scripps Research Institute (US).

  • Ph.D. Pharmacology UCM.

Leading Research Scientist in Pharmacology and Neurosciences focusing on clinical pharmacology of drugs of addiction. 

  • Director, Neurosciences Research Program, Hospital del Mar Research Centre (IMIM) and Hospital del Mar Clinical Pharmacology Unit.

  • Professor of Toxicology, Department of Experimental Sciences and Health, School of Biology, Pompeu Fabra University (Barcelona)

  • Member , UNDCP (United Nations Drug Control Program) Panel. 

  • Member, NCCLS (National Committees on Laboratory Standards-USA, Testing for Drugs of Abuse)

  • Deputy Head, Antidoping Laboratory Barcelona 1992 Olympic Games. 

  • Member, Editorial Board, Journal of Analytical Toxicology

  • 4 patents, 281 published scientific documents.

  • Post-Doctoral Fellow Clinical Pharmacology, McGill University (Montreal).

  • Royal Postgraduate Medical School, Hammersmith Hospital (London).

  • Pharm.D. Barcelona University.

Clinical investigator focusing on inflammation, intestinal permeability, liver damage  and cardiovascular health in patients with alcohol use disorder.

  • Attending physician, Internal Medicine Department at Germans Trias i Pujol University Hospital, Badalona.

  • Associate Professor, School of Medicine, Universitat Autonoma de Barcelona.

  • Member, College on Problems of Drug Dependence, USA.

  • Member, Spanish Society of Internal Medicine.

  • Associate editor, Addiction Science & Clinical Practice.

  • Post-doctoral fellow, Boston University School of Medicine.

  • Ph.D. in Medicine, Universitat Autonoma de Barcelona.

  • MD, Universitat de Barcelona.

Expert in Drug Development, Candidate Economic Valuation & Licensing.

  • Occupied global head and US head positions in drug development and therapeutic strategy in Sanofi and Merck.

  • Numerous licensing-in and licensing-out deals structured between mid-size biotech and big pharma companies.

  • 17 patents.

  • 18 scientific documents published.

  • Ph.D. Biophysics at Caltech (Pasadena).

  • BSE Bioengineering, University of Pennsylvania (US)

  • Benjamin Franklin Scholar.

Expert in Cognitive Effects of substance abuse.

  • Co-discoverer of the role of inflammatory and cannabinoid systems in alcohol related disorders.

  • Principal Investigator at IBIMA (Malaga), Neuropsychopharmacology of Addictive Disorders.

  • 177 scientific articles and meeting presentations.

  • Post-Doctoral Fellowship at the Scripps Research Institute (CA, US).

  • Ph.D., Biology, Malaga University (Spain).

  • B.S. and M.Sc. Biological Sciences, Malaga University (Spain).